![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Moderna Pauses Rare Disease Trials Due to COVID-19
Moderna Pauses Rare Disease Trials Due to COVID-19
Moderna has paused enrollment for its rare disease clinical trials due to the risk of disruption because of the COVID-19 outbreak.
The company said it has stopped new enrollment and site initiation for its rare disease trials with open IND applications.
Moderna is currently conducting clinical trials of its COVID-19 vaccine candidate, mRNA-1273, in collaboration with the National Institutes of Health.
Upcoming Events
-
18Jul
-
21Oct